noscript

News and Announcements

MedAdvisor AGM CEO Presentation

  • Published October 27, 2016 12:24PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

26th October 2016, ASX Announcement

FY16 Results Overview

  • Total revenue of $1.76m, representing a 24% increase on FY15 on a normalised basis
    – Normalised basis excludes a final license fee payment of $500,000 from FY15 revenue of $1.9 million
  • Revenue from pharmacy subscriptions and patient engagement programs (PEP) up 24% to $1.43 million
    – Additional revenue streams expected to go live during FY17
  • Gross profit of $925k, up 133% on FY15
  • Gross margin from pharmacy subscriptions increased to 71%, from 43% in the prior corresponding period
  • Net loss of $3.07 million due to increased costs and investments in expanding marketing and sales initiatives for further expansion in FY17

To view the full announcement, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now